What is it about?
Mediastinal lymph node enlargement is associated with survival in patients with interstitial lung disease and might be useful for risk stratification. Additionally, mediastinal lymph node enlargement is associated with severity of lung function impairment, risk of respiratory and all-cause hospitalization, and decreased plasma level of sCD40L.
Featured Image
Read the Original
This page is a summary of: Prognosticating Outcomes in Interstitial Lung Disease by Mediastinal Lymph Node Assessment: An Observational Cohort Study with Independent Validation, American Journal of Respiratory and Critical Care Medicine, September 2018, American Thoracic Society,
DOI: 10.1164/rccm.201804-0761oc.
You can read the full text:
Contributors
The following have contributed to this page
